Merck's Next Phase of Patient Centricity in R&D episode artwork

EPISODE · Nov 4, 2019 · 22 MIN

Merck's Next Phase of Patient Centricity in R&D

from PharmaTalkRadio · host Conference Forum

In this podcast, hear a session from the 2019 Patients as Partners EU meeting where Merck's Vanessa Pott presented a case study on Innovative Medicines Development and Merck KGaA's next phase of Patient Centricity in R&D.  The 4th annual Patients as Partners EU conference will take place on January 27-28, 2020 in London, UK. To learn more about the program and patient centricity in R&D, visit theconferenceforum.org.

Episode metadata supplied by the publisher feed · Published Nov 4, 2019

Embed this episode

Ready to play

Merck's Next Phase of Patient Centricity in R&D

0:00 22:25

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of PharmaTalkRadio?

This episode is 22 minutes long.

When was this PharmaTalkRadio episode published?

This episode was published on November 4, 2019.

Can I download this PharmaTalkRadio episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!